2026 Family Conference: Primary Prevention Update

Description: An update on the DIAN-TU Primary Prevention Trial, with focus on the drug candidate remternetug, along with updates on trial enrollment and funding
Runtime: 00:08:53

Speaker: Eric McDade, DO
Speaker title: DIAN Observational Study Director; DIAN Trials Unit Co-Director
Speaker organization: Washington University in St. Louis

Event: 2026 DIAD Family Conference: Dedicated to Impact
Location: London, United Kingdom
Year: 2026

Search tags: primary prevention, remternetug, donanemab, amyloid PET scan, disease progression, genetic testing, research participation, trial enrollment, mental health counseling, ethics, genetic status, grant renewal, research funding, advocacy, NIH funding